An Official Website of the United States Government
Company Information:
Name:
ALBANY MOLECULAR RESEARCH, INC.
Address:
21 CORPORATE CIRCLE
ALBANY, NY 12203
ALBANY, NY 12203
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
(518) 464-0279
Award Totals:
Award List:
26-Hydroxycholesterol--Therapy for Ctx and Restenosis
Award Year / Program / Phase:
1995 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Thomas D'ambra
Award Amount:
$100,000.00
Abstract:
26-Hydroxycholesterol is a naturally occurring metabolic product derived from cholesterol. Recent isuggest that this metabolite plays a role as a feedback inhibitor of cholesterol synthesis and may bregulation of LDL receptors. The absence of 26-hydroxycholesterol has been postulated to be the… More
DISCOVERY OF CDK INHIBITORS AS ANTITUMOR AGENTS
Award Year / Program / Phase:
1997 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Trova, michael p
Award Amount:
$100,000.00
Abstract:
The discovery of inhibitors of cyclin/cyclin dependent kinase (cdk) complexes is proposed which may have an antiprolifertive/antitumor effect of cells. Because overexpression of various cyclins have differential oncogenic potential, inhibitors will be assayed against a panel of cyclin/cdks. The… More
18 MC ANALOGS AS POTENTIAL ANTIADDICTIVE AGENTS
Award Year / Program / Phase:
1998 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Pilling, Garry M
Award Amount:
$99,489.00
SYNTHESIS OF 18-METHOXYCORONARIDINE HYDROCHLORIDE
Award Year / Program / Phase:
1999 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Chihsin R. King
Award Amount:
$100,000.00
Abstract:
Not Available Ceradyne is proposing enhanced based armor (EBA) technology for protecting the AAAV. The EBA technology is based on several components (made of different materials), combined together to achieve enhanced capabilities. The proposal details alternative design solutions based on existing… More
N/A
Award Year / Program / Phase:
2000 / SBIR / Phase I
Agency:
DOE
Principal Investigator:
Joseph O. Rich, Senior Scientist
Award Amount:
$100,000.00
N/A
Award Year / Program / Phase:
2001 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$98,466.00
Biocatalytic Synthesis of Selective D1 Agonists
Award Year / Program / Phase:
2001 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Peter C. Michels
Award Amount:
$192,199.00
Abstract:
DESCRIPTION (provided by applicant): "Drug addition is a complex illness. It is
characterized by compulsive, at times uncontrollable drug craving, seeking, and
use that persist even in the face of extremely negative consequences." As a
consequence of the extraordinary personal,… More